Axonics (AXNX) Competitors

Cantel Medical (NYSE:CMD) and Axonics (NASDAQ:AXNX) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Is CMD or AXNX more profitable?

Cantel Medical has a net margin of 4.72% compared to Axonics' net margin of -1.31%. Cantel Medical's return on equity of 12.13% beat Axonics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cantel Medical	4.72%	12.13%	4.45%
Axonics	-1.31%	0.36%	0.31%

Which has more risk and volatility, CMD or AXNX?

Cantel Medical has a beta of 1.55, meaning that its stock price is 55% more volatile than the S&P 500. Comparatively, Axonics has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500.

Does the media refer more to CMD or AXNX?

In the previous week, Axonics had 7 more articles in the media than Cantel Medical. MarketBeat recorded 7 mentions for Axonics and 0 mentions for Cantel Medical. Axonics' average media sentiment score of 0.91 beat Cantel Medical's score of 0.00 indicating that Axonics is being referred to more favorably in the news media.

Company	Overall Sentiment
Cantel Medical	Neutral
Axonics	Positive

Which has stronger earnings & valuation, CMD or AXNX?

Cantel Medical has higher revenue and earnings than Axonics. Axonics is trading at a lower price-to-earnings ratio than Cantel Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cantel Medical	$1.02B	3.52	$13.71M	$1.65	48.71
Axonics	$366.38M	9.90	-$6.09M	-$0.12	-591.45

Do analysts rate CMD or AXNX?

Axonics has a consensus price target of $71.00, suggesting a potential upside of 0.03%. Given Axonics' stronger consensus rating and higher possible upside, analysts plainly believe Axonics is more favorable than Cantel Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cantel Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Axonics	0 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the MarketBeat Community prefer CMD or AXNX?

Cantel Medical received 37 more outperform votes than Axonics when rated by MarketBeat users. However, 66.41% of users gave Axonics an outperform vote while only 65.53% of users gave Cantel Medical an outperform vote.

Company	Underperform	Outperform
Cantel Medical	Outperform Votes 211 65.53%	Underperform Votes 111 34.47%
Axonics	Outperform Votes 174 66.41%	Underperform Votes 88 33.59%

Do institutionals and insiders believe in CMD or AXNX?

84.1% of Cantel Medical shares are owned by institutional investors. Comparatively, 99.5% of Axonics shares are owned by institutional investors. 10.7% of Cantel Medical shares are owned by insiders. Comparatively, 1.9% of Axonics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Cantel Medical beats Axonics on 10 of the 17 factors compared between the two stocks.